|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1201 Maryland Avenue SW |
Address2 | Suite 900 |
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 6245-12
|
||||||||
|
6. House ID# 325050000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Brent DelMonte, Vice President for Federal Government Relations |
Date | 01/21/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ACC
16. Specific lobbying issues
Sarbanes-Oxley Reform
Section 404
H.R. 7323/S.3260: Financial Services and General Government Appropriations Act for FY 2009
Modification/Extension of R&D/AMT Tax Credits in Lieu of Bonus Depreciation
H.R. 7327: Worker, Retiree, and Employer Recovery Act of 2008
S.1: American Recovery & Reinvestment Act of 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Tooshar |
Swain |
|
Legislative Correspondent, Senator Rick Santorum |
|
Shelly |
Mui-Lipnik |
|
|
|
Paul |
Poteet |
|
|
|
Alan |
Eisenberg |
|
|
|
Brent |
DelMonte |
|
|
|
Eli |
Joseph |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
U.S. Policy on Sustainable Agriculture Standard
American National Standards Institute (ANSI)
Livestock Cloning/Product Labeling
FDA Risk Assessment on Cloning
USDA Marketing and Regulatory Programs, Cloning Transition Period
USDA Economic Report on Impact of Cloning on US Agriculture and Food Production
USDA National Organic Program, Advance Notice of Proposed Rulemaking
S: 3289: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY
2009
Foreign Agricultural Biotechnology Laws and Regulations
U.S. Korea Free Trade Agreement
China Biotechnology Bilateral Discussions
Mexico Biotechnology Bilateral Discussions
Taiwan Biotechnology Bilateral Discussions
EU Biotechnology Discussions
Canada Biotechnology Bilateral Discussions
Japan Biotechnology Bilateral Discussions
Peru Biotechnology Bilateral Discussions
Argentina Biotechnology Bilateral Discussions
Brazil Biotechnology Bilateral Discussions
Paraguay Biotechnology Bilateral Discussions
Transpacific Economic Partnership
Adventitious Presence (Low Level Presence)
U.S. Government Policy Position for Codex Guidelines on Adventitious Presence
European Union Low Level Presence Policy
World Trade Organization on EU Biotech Approvals
Review of EU Biotechnology Negotiations
Genetically Engineered (GE) Animals
FDA and USDA Draft Regulation of GE Animals
Biotechnology Crop Stewardship
Biotechnology Quality Management Stewardship
Cartagena Biosafety Protocol
U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings
USDA/APHIS Agricultural Biotechnology Regulations
USDA Rulemaking on 7 CFR 340
International Standards Organization Standards
American National Standards Institute (ANSI)
Policies Impacting Global Trade of Ag-Biotech Products
U.S. Government Positions
Asia Pacific Economic Cooperation Forum Participation
Funding for the USDA
S:3289: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY
2009
Biomass Crop Assistance Program
BCAP Rulemaking and Environmental Impact Statement
International Biotechnology Education
Government Education Programs
Coordinated Regulatory Framework for Ag. Biotechnology
GAO Report
17. House(s) of Congress and Federal agencies Check if None
Agriculture - Dept of (USDA), U.S. Trade Representative (USTR), Commerce - Dept of (DOC), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), State - Dept of (DOS), U.S. Agency for International Development (USAID), Office of Science & Technology Policy (OSTP), Office of Management & Budget (OMB), Environmental Protection Agency (EPA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
Barbara |
Glenn |
|
|
|
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Sarah |
Lukie |
|
|
|
Bill |
Olson |
|
Legislative Assistant, Rep. John Shimkus |
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Genetically Engineered (GE) Animals
FDA and USDA Draft Regulation of GE Animals
Livestock Cloning/Product Labeling
FDA Risk Assessment on Cloning
USDA Marketing and Regulatory Programs, Cloning Transition Period
USDA Economic Report on Impact of Cloning on US Agriculture and Food Production
USDA National Organic Program, Advance Notice of Proposed Rulemaking
S: 3289: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY
2009
17. House(s) of Congress and Federal agencies Check if None
Agriculture - Dept of (USDA), Health & Human Services - Dept of (HHS), U.S. Trade Representative (USTR), State - Dept of (DOS), Commerce - Dept of (DOC), Food & Drug Administration (FDA), Office of Science & Technology Policy (OSTP), Office of Management & Budget (OMB), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
Barbara |
Glenn |
|
|
|
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S: 3289: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009
Funding for the Food and Drug Administration (Human Drug, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation,
Center for Veterinary Medicine)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 (Cont...)
Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Service (APHIS), Animal Care &
Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture
Research Service, Biofuels (Rural Development))
Drug Importation
Livestock Cloning/Product Labeling
S: 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
Funding for National Institutes of Health
Funding for Bioterrorism and Emergency Preparedness
Funding for Pandemic Influenza Preparedness
Funding for Biomedical Advanced Research & Development Authority (BARDA)
Drug Importation
S: 3258/H.R. 7324: Energy and Water Development and Related Agencies Appropriations Act for FY 2009
Funding for Biofuels
H.R. 7323/S.3260: Financial Services and General Government Appropriations Act for FY 2009
Sarbanes Oxley - Section 404
H.R. 7322/S: 3282: Commerce, Justice, Science, and Related Agencies Appropriations Act for FY 2009
Funding for Technology Innovation Program (TIP)
S.3288: Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2009
Funding for Biotechnology Research and Development Programs at the Agency for International Development
H.R. 2642: Supplemental Appropriations Bill
Funding for National Institutes of Health
Funding for Bioterrorism and Emergency Preparedness
Funding for Pandemic Influenza Preparedness
Funding for the Food and Drug Administration
Funding for Biomedical Advanced Research & Development Authority (BARDA)
H.R. 7110/S.3604/S.3688: Job Creation and Unemployment Relief Act for 2008
Funding for National Institutes of Health
Funding for Bioterrorism and Emergency Preparedness
Funding for Pandemic Influenza Preparedness
Funding for the Food and Drug Administration
Funding for Biomedical Advanced Research & Development Authority (BARDA)
S.3181: Department of Homeland Security Appropriations Act for FY 2009
Drug Importation
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Agriculture - Dept of (USDA), U.S. Trade Representative (USTR), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Sara |
Radcliffe |
|
|
|
Sharon |
Bomer Lauritsen |
|
|
|
John |
Taylor |
|
|
|
Tricia |
Brooks |
|
|
|
Daryl |
Pritchard |
|
|
|
Melissa |
Bowie |
|
Chief Health Counsel, Senate HELP, Subcommittee |
|
Brent |
DelMonte |
|
|
|
Jeanne |
Haggerty |
|
|
|
Eli |
Joseph |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Patent Reform
H.R. 1908
S. 1145
S.3600
PTO Reform
CBD TRIPS Amendment
Patent Disclosure Requirements
Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World
U.S. Government Positions in WTO, WHO Negotiations
Intellectual Property Enforcement
S.3464
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Patent & Trademark Office (PTO), State - Dept of (DOS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lila |
Feisee |
|
|
|
Tom |
DiLenge |
|
|
|
Hansjorg |
Sauer |
|
|
|
John |
Taylor |
|
|
|
Melissa |
Bowie |
|
Chief Health Counsel, Senate HELP Subcommittee |
|
Paul |
Poteet |
|
|
|
Edward |
Buckley |
|
|
|
Jeanne |
Haggerty |
|
|
|
Tricia |
Brooks |
|
|
|
Eli |
Joseph |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Genetically Engineered (GE) Animals
FDA and USDA Draft Regulation of GE Animals
Drug Safety
Implementation of Food & Drug Administration Amendments Act of 2007
Clinical Trial Registry and Results Databases
Heparin Contamination
E-Pedigree and Anti-counterfeiting
H.R. 5839: Safeguarding America's Pharmaceuticals Act of 2008
FDA Globalization Act of 2008
S.3409: The Drug and Device Accountability Act of 2008
Drug Importation
S: 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
S. 3181: Department of Homeland Security Appropriations Act for FY 2009
S: 3289: Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2009
Adventitious Presence (Low Level Presence)
U.S. Government Policy Position for Codex Guidelines on Adventitious Presence
European Union Low Level Presence
Livestock Cloning/Product Labeling
FDA Risk Assessment on Cloning
USDA Marketing and Regulatory Programs, Cloning Transition Period
USDA Economic Report on Impact of Cloning on US Agriculture and Food Production
USDA National Organic Program, Advance Notice of Proposed Rulemaking
S: 3289: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY
2009
Funding for Food Safety at the Food and Drug Administration
S: 3289: Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2009
17. House(s) of Congress and Federal agencies Check if None
Agriculture - Dept of (USDA), Health & Human Services - Dept of (HHS), U.S. Trade Representative (USTR), State - Dept of (DOS), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Commerce - Dept of (DOC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Barbara |
Glenn |
|
|
|
Sharon |
Bomer Lauritsen |
|
|
|
John |
Taylor |
|
|
|
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Patricia |
Brooks |
|
|
|
Sara |
Radcliffe |
|
|
|
Jeanne |
Haggerty |
|
|
|
Andrew |
Emmett |
|
|
|
Cartier |
Esham |
|
|
|
Tom |
DiLenge |
|
|
|
Sarah |
Lukie |
|
|
|
Brent |
DelMonte |
|
|
|
Melissa |
Bowie |
|
Chief Health Counsel, Senate HELP Subcommittee |
|
Bill |
Olson |
|
Legislative Assistant, Rep. John Shimkus |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Renewable Fuels Standard
EPA Rulemaking on Life Cycle Greenhouse Gas Emissions Requirements
Biofuels
Funding for Biofuels
Production Tax Credits
Investment in Commercialization of Advanced Biofuels
Investment in Biofuels Products Distribution and Delivery Infrastructure
S. 1: American Recovery & Reinvestment Act of 2009
H.R. 7324/S.3258: Energy and Water Development and Related Agencies Appropriations Act for FY 2009
Bio-based Products
Production Tax Credits
Investment in Bio-based Products Distribution and Delivery Infrastructure
S.1: American Recovery & Reinvestment Act of 2009
2009 Energy Bill Proposal
Biomass Crop Assistance Program
Biorefinery Loan Guarantees
Bioenergy Program
Renewable Fuels Standard
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Energy - Dept of, Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brent |
Erickson |
|
|
|
Amy |
Ehlers |
|
|
|
Matt |
Carr |
|
|
|
Bill |
Olson |
|
Legislative Assistant, Rep. John Shimkus |
|
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Brent |
DelMonte |
|
|
|
Paul |
Poteet |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Adventitious Presence (Low Level Presence)
U.S. Government Policy Position for codex Guidelines on Adventitious Presence
European Union Low Level Presence Policy
Genetically Engineered (GE) Animals
FDA and USDA Draft Regulation of GE Animals
Livestock Cloning/Product Labeling
FDA Risk Assessment on Cloning
USDA Marketing and Regulatory Programs, Cloning Transition Period
USDA Economic Report on Impact of Cloning on US Agriculture and Food Production
USDA National Organic Program, Advance Notice of Proposed Rulemaking
S: 3289: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY
2009
Funding for Food Safety at the Food and Drug Administration
S: 3289: Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Commerce - Dept of (DOC), Food & Drug Administration (FDA), State - Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
Barbara |
Glenn |
|
|
|
Sarah |
Lukie |
|
|
|
John |
Taylor |
|
|
|
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Brent |
DelMonte |
|
|
|
Bill |
Olson |
|
Legislative Assistant, Rep. John Shimkus |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FUE
16. Specific lobbying issues
Renewable Fuels Standard
EPA Rulemaking on Life Cycle Greenhouse Gas Emissions Requirements
Biofuels
Funding for Biofuels
Production Tax Credits
Investment in Commercialization of Advanced Biofuels
Investment in Biofuels Products Distribution and Delivery Infrastructure
S. 1: American Recovery & Reinvestment Act of 2009
H.R. 7324/S.3258: Energy and Water Development and Related Agencies Appropriations Act for FY 2009
Bio-based Products
Production Tax Credits
Investment in Bio-based Products Distribution and Delivery Infrastructure
S.1: American Recovery & Reinvestment Act of 2009
2009 Energy Bill Proposal
Biomass Crop Assistance Program
Biorefinery Loan Guarantees
Bioenergy Program
Renewable Fuels Standard
17. House(s) of Congress and Federal agencies Check if None
Agriculture - Dept of (USDA), Energy - Dept of, Environmental Protection Agency (EPA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Ehlers |
|
|
|
Matt |
Carr |
|
|
|
Brent |
Erickson |
|
|
|
Bill |
Olson |
|
Legislative Assistant, Rep. John Shimkus |
|
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Brent |
DelMonte |
|
|
|
Paul |
Poteet |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Drug Safety
Implementation of Food & Drug Administration Amendments Act of 2008
Clinical Trial Registry and Results Databases
Drug Safety Cont...
Heparin Contamination
FDA Globalization Act of 2008
E-Pedigree and Anti-counterfeiting
H.R. 5839 Safeguarding America's Pharmaceuticals Act of 2008
S.3409: The Drug and Device Accountability Act of 2008
Funding for the Food and Drug Administration
S.3289:Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for
FY 2009
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
Stem Cell Research
Medicaid Rebates
Medicaid/Medicare Packages
Dual Proportionality
Follow-on Biologics
H.R. 1038
H.R. 1956
H.R. 5629
S. 1695
Federal Trade Commission Review of Competition & IP Issues
FDA Regulatory Processes for First-Time Filers
Funding for Biomedical Advanced Research & Development Authority (BARDA)
S: 3230: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations
Act for FY 2009
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
Vaccine Financing
National Vaccine Advisory Committee Draft Recommendations
Outpatient Prospective Payment System
S. 3101: Medicare Improvements for Patients and Providers Act of 2008
CMS ASP + 4% Proposed Regulation
Medicare Reimbursement in Hospital Outpatient Setting
Comparative Effectiveness Program Initiatives
S. 3101
S.3408
International Market Access for U.S. Healthcare Products
Alliance for Healthcare Competitiveness
Funding for National Institutes of Health
S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
Funding for Bioterrorism and Emergency Preparedness
S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
Funding for Pandemic Influenza Preparedness
S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
Drug Importation
S.3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
S. 3181: Department of Homeland Security Appropriations Act for FY 2009
S. 3289: Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2009
Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World
U.S. Government Positions in WTO, WHO Negotiations
17. House(s) of Congress and Federal agencies Check if None
Centers For Medicare and Medicaid Services (CMS), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Federal Trade Commission (FTC), U.S. Trade Representative (USTR), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), Commerce - Dept of (DOC), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeanne |
Haggerty |
|
|
|
John |
Taylor |
|
|
|
Sara |
Radcliffe |
|
|
|
Cartier |
Esham |
|
|
|
Andrew |
Emmett |
|
|
|
Tricia |
Brooks |
|
|
|
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Melissa |
Bowie |
|
Chief Health Counsel, Senate HELP Subcommittee |
|
Kelly |
Lai |
|
|
|
Edward |
Buckley |
|
|
|
Sandra |
Dennis |
|
|
|
Hansjorg |
Sauer |
|
|
|
Lauren |
Neff |
|
Leg. Asst., Congresswoman Deborah Pryce |
|
Laurel |
Todd |
|
|
|
Paul |
Poteet |
|
|
|
Daryl |
Pritchard |
|
|
|
Tom |
DiLenge |
|
|
|
Lila |
Feisee |
|
|
|
Eli |
Joseph |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
Funding for Pandemic Influenza Preparedness
S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
Funding for Pandemic Influenza Preparedness cont...
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
Funding for Biomedical Advanced Research Development Authority (BARDA)
S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
Funding for Bioterrorism and Emergency Preparedness
S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Sara |
Radcliffe |
|
|
|
Melissa |
Bowie |
|
Chief Health Counsel, Senate HELP Subcommittee |
|
John |
Taylor |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Funding for National Institutes of Health
S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for
FY 2009
Funding for National Institutes of Health cont...
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
Funding for Biomedical Advanced Research Development Authority (BARDA)
S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
Funding for the Food and Drug Administration
S.3289: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY
2009
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
Funding for Bioterrorism and Emergency Preparedness
S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
Funding for Pandemic Influenza Preparedness
S. 3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
Comparative Effectiveness Program Initiatives
S. 3101
S.3408
Stem Cell Research
Drug Safety
Implementation of Food & Drug Administration Amendments Act of 2007
Clinical Trial Registry and Results Databases
17. House(s) of Congress and Federal agencies Check if None
Health & Human Services - Dept of (HHS), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Food & Drug Administration (FDA), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Daryl |
Pritchard |
|
|
|
Tricia |
Brooks |
|
|
|
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Jeanne |
Haggerty |
|
|
|
Laurel |
Todd |
|
|
|
John |
Taylor |
|
|
|
Edward |
Buckley |
|
|
|
Andrew |
Emmett |
|
|
|
Sara |
Radcliffe |
|
|
|
Sandra |
Dennis |
|
|
|
Cartier |
Esham |
|
|
|
Tom |
DiLenge |
|
|
|
Lauren |
Neff |
|
Leg. Assistant, Congresswoman Deborah Pryce |
|
Brent |
DelMonte |
|
|
|
Melissa |
Bowie |
|
Chief Health Counsel, Senate HELP Subcommittee |
|
Eli |
Joseph |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Outpatient Prospective Payment System
S. 3101: Medicare Improvements for Patients and Providers Act of 2008
CMS ASP+ 4% Proposed Regulation
Medicare Reimbursements in Hospital Outpatient Department Setting
Medicaid Rebates
Medicaid/Medicare Packages
Dual Proportionality
17. House(s) of Congress and Federal agencies Check if None
Centers For Medicare and Medicaid Services (CMS), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jeanne |
Haggerty |
|
|
|
Laurel |
Todd |
|
|
|
Lauren |
Neff |
|
Leg. Asst., Congresswoman Deborah Pryce |
|
Sandra |
Dennis |
|
|
|
John |
Taylor |
|
|
|
Melissa |
Bowie |
|
Chief Health Counsel, Senate HELP, Subcommittee |
|
Brent |
DelMonte |
|
|
|
Eli |
Joseph |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Comparative Effectiveness Program Initiatives
S. 3101
S.3408
Medicaid Rebates
Medicaid/Medicare Packages
Dual Proportionality
Outpatient Prospective Payment System
S. 3101: Medicare Improvements for Patients and Providers Act of 2008
CMS ASP+ 4% Proposed Regulation
Medicare Reimbursement in Hospital Outpatient Department Setting
Drug Importation
S.3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
S. 3181: Department of Homeland Security Appropriations Act for FY 2009
S. 3289: Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2009
Drug Safety
Implementation of Food & Drug Administration Amendments Act of 2007
Clinical Trial Registry and Results Databases
Heparin Contamination
FDA Globalization Act of 2008
E-Pedigree and Anti-counterfeiting
H.R. 5839 Safeguarding America's Pharmaceuticals Act of 2008
S.3409: The Drug and Device Accountability Act of 2008
Funding for the Food and Drug Administration
S.3289:Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for
FY 2009
H.R. 2642: Supplemental Appropriations Act for FY 2008
H.R. 7110/S.3604/S.3689: Job Creation and Unemployment Relief Act
17. House(s) of Congress and Federal agencies Check if None
U.S. Trade Representative (USTR), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
John |
Taylor |
|
|
|
Sandra |
Dennis |
|
|
|
Melissa |
Bowie |
|
Chief Health Counsel, Senate HELP Subcommittee |
|
Lauren |
Neff |
|
Leg. Assistant, Congresswoman Deborah Pryce |
|
Sara |
Radcliffe |
|
|
|
Cartier |
Esham |
|
|
|
Andrew |
Emmett |
|
|
|
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Tricia |
Brooks |
|
|
|
Edward |
Buckley |
|
|
|
Jeanne |
Haggerty |
|
|
|
Laurel |
Todd |
|
|
|
Brent |
DelMonte |
|
|
|
Tom |
DiLenge |
|
|
|
Eli |
Joseph |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Stem Cell Research
Small Business Innovation and Research Program (SBIR)
H.R. 5819: SBIR Reauthorization Act
S.3362
Modification/Extension of R&D/AMT Tax Credits in Lieu of Bonus Depreciation
H.R. 7327: Worker, Retiree, and Employer Recovery Act of 2008
S.1. American Recovery & Reinvestment Act of 2009
Technology Innovation Program (TIP)
Funding
S:3282: Commerce, Justice, Science, and Related Agencies Appropriations Act for FY 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Small Business Adminstration (SBA), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Poteet |
|
|
|
Cartier |
Esham |
|
|
|
Tricia |
Brooks |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Tooshar |
Swain |
|
Legislative Correspondent, Senator Rick Santorum |
|
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Tom |
DiLenge |
|
|
|
Alan |
Eisenberg |
|
|
|
Brent |
DelMonte |
|
|
|
Eli |
Joseph |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Small Business Innovation and Research Program (SBIR)
H.R. 5819: SBIR Reauthorization Act
S.3362
Sarbanes-Oxley Reform
Section 404
H.R. 7323/S.3260:Financial Services and General Government Appropriations Act for FY 2009
FDA Regulatory Processes for First-Time Filers
Modification/Extension of R&D/AMT Tax Credits in Lieu of Bonus Depreciation
H.R. 7327: Worker, Retiree, and Employer Recovery Act of 2008
S.1: American Recovery & Reinvestment Act of 2009
Net Operating Losses Monetization Tax Proposal
S.1: American Recovery & Reinvestment Act of 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Small Business Adminstration (SBA), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tricia |
Brooks |
|
|
|
Cartier |
Esham |
|
|
|
Alan |
Eisenberg |
|
|
|
Paul |
Poteet |
|
|
|
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Shelly |
Mui-Lipnik |
|
|
|
Tooshar |
Swain |
|
Legislative Correspondent, Senator Rick Santorum |
|
Tom |
DiLenge |
|
|
|
Brent |
DelMonte |
|
|
|
Eli |
Joseph |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Biofuels
Production Tax Credit
Bio-Based Products
Production Tax Credit
Modification/Extension of R&D/AMT Tax Credits in Lieu of Bonus Depreciation
H.R. 7327: Worker, Retiree, and Employer Recovery Act of 2008
S. 1: American Recovery & Reinvestment Act of 2009
Net Operating Losses Monetization Tax Proposal
S.1: American Recovery & Reinvestment Act of 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Ehlers |
|
|
|
Matt |
Carr |
|
|
|
Brent |
Erickson |
|
|
|
Paul |
Poteet |
|
|
|
Tooshar |
Swain |
|
Legislative Correspondent, Senator Rick Santorum |
|
Shelly |
Mui-Lipnik |
|
|
|
Alan |
Eisenberg |
|
|
|
Tricia |
Brooks |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Cartagena Biosafety Protocol
U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings
Foreign Agricultural Biotechnology Laws and Regulations
U.S. Korea Free Trade Agreement
China Biotechnology Bilateral Discussions
Mexico Biotechnology Bilateral Discussions
Taiwan Biotechnology Bilateral Discussions
EU Biotechnology Bilateral Discussions
Canada Biotechnology Bilateral Discussions
Japan Biotechnology Bilateral Discussions
Peru Biotechnology Bilateral Discussions
Argentina Biotechnology Bilateral Discussions
Brazil Biotechnology Bilateral Discussions
Paraguay Biotechnology Bilateral Discussions
Transpacific Economic Partnership
Adventitious Presence (Low Level Presence)
U.S. Government Policy Position for Codex Guidelines on Adventitious Presence
European Union Low Level Presence Policy
World Trade Organization on EU Biotech Approvals
Review of EU Biotechnology Negotiations
CBD TRIPS Amendment
Patent Disclosure Requirements
Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World
U.S. Government Positions in WTO, WHO Negotiations
Policies Impacting Global Trade of Ag-Biotech Products
Asia Pacific Economic Cooperation Forum Participation
U.S. Government Positions
International Market Access for U.S. Healthcare Products
Alliance for Healthcare Competitiveness
Intellectual Property Enforcement
S.3464
Drug Importation
S.3230: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY
2009
S. 3181: Department of Homeland Security Appropriations Act for FY 2009
S. 3289: Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), Commerce - Dept of (DOC), State - Dept of (DOS), U.S. Trade Representative (USTR), U.S. Agency for International Development (USAID), Health & Human Services - Dept of (HHS), Patent & Trademark Office (PTO),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
Sarah |
Lukie |
|
|
|
Lila |
Feisee |
|
|
|
Kelly |
Lai |
|
|
|
Paul |
Poteet |
|
|
|
John |
Taylor |
|
|
|
Patrick |
Carroll |
|
Legislative Assistant, Congressman LaHood |
|
Hansjorg |
Sauer |
|
|
|
Tom |
Dilenge |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
GOV |
|
|
|
|
|
|
|
|
LAW |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: BIO maintains a list of all of its members on its website at http://bio.org/membership/index.asp
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |